<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34906986</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2059-7908</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>BMJ global health</Title><ISOAbbreviation>BMJ Glob Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e006838</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjgh-2021-006838</ELocationID><Abstract><AbstractText Label="BACKGROUND">The objective of this study was to identify the prevalence of long COVID symptoms in a large cohort of people living with and affected by long COVID and identify any potential associated risk factors.</AbstractText><AbstractText Label="METHODS">A prospective survey was undertaken of an inception cohort of confirmed people living with and affected by long COVID (aged 18-87 years). 14392 participants were recruited from 24 testing facilities across Bangladesh between June and November 2020. All participants had a previously confirmed positive COVID-19 diagnosis, and reported persistent symptoms and difficulties in performing daily activities. Participants who consented were contacted by face-to-face interview, and were interviewed regarding long COVID, and restriction of activities of daily living using post COVID-19 functional status scale. Cardiorespiratory parameters measured at rest (heart rate, systolic blood pressure, diastolic blood pressure, oxygen saturation levels, maximal oxygen consumption, inspiratory and expiratory lung volume) were also measured.</AbstractText><AbstractText Label="RESULTS">Among 2198 participants, the prevalence of long COVID symptoms at 12 weeks was 16.1%. Overall, eight long COVID symptoms were identified and in descending order of prominence are: fatigue, pain, dyspnoea, cough, anosmia, appetite loss, headache and chest pain. People living with and affected by long COVID experienced between 1 and 8 long COVID symptoms with an overall duration period of 21.8&#xb1;5.2 weeks. Structural equation modelling predicted the length of long COVID to be related to younger age, female gender, rural residence, prior functional limitation and smoking.</AbstractText><AbstractText Label="CONCLUSION">In this cohort, at 31 weeks post diagnosis, the prevalence of long COVID symptoms was 16.1%. The risk factors identified for presence and longer length of long COVID symptoms warrant further research and consideration to support public health initiatives.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Mohammad Anwar</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiotherapy, Centre for Rehabilitation of the Paralysed, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>K M Amran</ForeName><Initials>KMA</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Bangladesh Health Professions Institute, Savar, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Zakir</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walton</LastName><ForeName>Lori Maria</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, School of Health Sciences, University of Scranton, Scranton, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raigangar</LastName><ForeName>Veena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, College of Health Sciences, University of Sharjah, Sharjah, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakel</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>East Kent Neurorehabilation Department, East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafin</LastName><ForeName>Rubayet</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Centre for Rehabilitation of the Paralysed, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Mohammad Sohrab</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Bangladesh Health Professions Institute, Savar, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabir</LastName><ForeName>Md Feroz</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy &amp; Rehabilitation, Jashore University of Science and Technology, Jashore, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faruqui</LastName><ForeName>Rafey</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neuropsychiatry, Kent and Medway NHS and Social Care Partnership Trust, Maidstone, Kent, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Md Shohag</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-8404-5203</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Bangladesh Health Professions Institute, Savar, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Md Shahoriar</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Centre for Rehabilitation of the Paralysed, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakrovorty</LastName><ForeName>Sonjit Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Md Anwar</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Dhaka, Dhaka, Bangladesh.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vice-Chancellor, Jashore University of Science and Technology, Jashore, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahid</LastName><ForeName>Iqbal Kabir</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jashore University of Science and Technology, Jashore, Bangladesh ikjahid_mb@just.edu.bd.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Glob Health</MedlineTA><NlmUniqueID>101685275</NlmUniqueID><ISSNLinking>2059-7908</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001459" MajorTopicYN="N" Type="Geographic">Bangladesh</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089382" MajorTopicYN="N">Oxygen Saturation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34906986</ArticleId><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="doi">10.1136/bmjgh-2021-006838</ArticleId><ArticleId IdType="pii">bmjgh-2021-006838</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-Acute COVID-19 syndrome. Nat Med 2021;27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE (National Institute for Health and Care Excellence) . COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline, 2020. Available: https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E, Callard F, Stras L. Why the Patient-Made Term 'Long Covid' is needed [version 1; peer review: 1 approved with reservations, 1 not approved] 2020;5:224.</Citation></Reference><Reference><Citation>Long-term effects of coronavirus (long COVID) [Internet]. nhs.uk, 2021. Available: https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-effects-of-coronavirus-long-covid/ [Accessed 17 Aug 2021].</Citation></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. . Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021;372:n693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratiuk AL, Pillay TD, Kon OM, et al. . A conceptual framework to accelerate the clinical impact of evolving research into long COVID. Lancet Infect Dis 2021;21:756&#x2013;7. 10.1016/S1473-3099(21)00136-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00136-5</ArticleId><ArticleId IdType="pmc">PMC8062085</ArticleId><ArticleId IdType="pubmed">33894903</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-Month consequences of COVID-19 in patients discharged from Hospital: a cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al. . Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health 2021;18:2621. 10.3390/ijerph18052621</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020;370:m3489. 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 July 2021, 2021. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1july2021</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V. Scientists set out to connect the dots on long COVID. Nat Methods 2021;18:449&#x2013;53. 10.1038/s41592-021-01145-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01145-z</ArticleId><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G, Long Covid Forum Group . Research priorities for long Covid: refined through an international multi-stakeholder forum. BMC Med 2021;19:84. 10.1186/s12916-021-01947-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01947-0</ArticleId><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwu CJ, Iwu CD, Wiysonge CS. The occurrence of long COVID: a rapid review. Pan Afr Med J 2021;38:65. 10.11604/pamj.2021.38.65.27366</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.65.27366</ArticleId><ArticleId IdType="pmc">PMC8028365</ArticleId><ArticleId IdType="pubmed">33889231</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangladesh population (live) accessed via Worldometer, 2021. Available: https://www.worldometers.info/world-population/bangladesh-population/</Citation></Reference><Reference><Citation>Islam MS, Ferdous MZ, Islam US. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health 20212021;18. [Epub ahead of print: 05 02 2021]. 10.3390/ijerph18041453</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041453</ArticleId><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, Rahman MM, Rassel MA, et al. . Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One 2021;16:e0249644. 10.1371/journal.pone.0249644</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland clinic website, 2021. Available: https://my.clevelandclinic.org/health/diagnostics/21462-covid-19-and-pcr-testing</Citation></Reference><Reference><Citation>World Health Organization (WHO) . Health emergency Dashboard. Bangladesh. who (COVID-19) Homepage, 2021. Available: https://covid19.who.int/region/searo/country/bd</Citation></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, et al. . Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297. 10.1371/journal.pmed.0040297</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040297</ArticleId><ArticleId IdType="pmc">PMC2020496</ArticleId><ArticleId IdType="pubmed">17941715</ArticleId></ArticleIdList></Reference><Reference><Citation>Dghs.gov.bd, 2021. Available: https://dghs.gov.bd/images/docs/Guideline/COVID_Guideline_v2_8_5_21.pdf [Accessed 23 Aug 2021].</Citation></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, et al. . The Post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J 2020;56:2001494. 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FVC, Meys R, Delbressine JM, et al. . Construct validity of the Post-COVID-19 functional status scale in adult subjects with COVID-19. Health Qual Life Outcomes 2021;19:40. 10.1186/s12955-021-01691-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) . Process of translation and adaptation of instruments, 2021. Available: https://www.who.int/substance_abuse/research_tools/translation/en/</Citation></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection . A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020;20:e192-e197. 10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. . Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax 2021;76:405&#x2013;7. 10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare Workers [Internet]. Centers for Disease Control and Prevention, 2021. Available: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html [Accessed 29 Sep 2021].</Citation></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 2021;4:e210830. 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 2021;93:1013&#x2013;22. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021;6:100122. 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>World.physio, 2021. Available: https://world.physio/sites/default/files/2021-07/Briefing-Paper-9-Long-Covid-FINAL-English-2021_0.pdf [Accessed 25 Sep 2021].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>